MedTrace Logo

Colonic Transit Time Validation Study

NCT00857363 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 210

Last updated 2010-01-15

No results posted yet for this study

Summary

The protocol described herein is designed to provide clinical evidence of the substantial equivalence of SmartPill GI Monitoring System (SP) to the Sitzmarks (Konsyl Pharmaceuticals, Easton, MD) radio-opaque markers (ROM). The trial will enroll symptomatic subjects who meet Rome III criteria (1) for chronic functional constipation.

Conditions

Sponsors & Collaborators

  • The SmartPill Corporation

    lead INDUSTRY

Principal Investigators

  • John R Semler, PHD · The SmartPill Corporation

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-05-31
Completion
2009-06-30

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00857363 on ClinicalTrials.gov